User login
Valuable Strategies to Reduce the Risk for and Clinical Impact of Hyperkalemia
7:30 – 9:30 p.m. – Canary Room 1-2
Dinner provided at 7:30 p.m.
Presenters: Biff F. Palmer, MD, professor of internal medicine, University of Texas Southwestern Medical Center, Dallas; Robert Toto, MD, associate dean, clinical and translational research, director, Center for Translational Medicine, UT Southwestern Medical Center, Dallas.
Overview: The goal of the case-based symposium is to highlight patients at increased risk of recurrent or sustained hyperkalemia and how these patients may be managed with evidence-based treatment so that they are able to continue renin-angiotensin-aldosterone system inhibitor therapy, if appropriate. The presenters will share their experiences in managing these patients, including suggestions for the hospitalist’s role in continued care.
Accreditation: This activity has been approved for AMA PRA Category 1 Credit(s)™. See final CE activity announcement for specific details.
This activity is supported by an educational grant from Relypsa Inc.
Hepatology News Tonight: Managing Complication of Cirrhosis
7:30 – 9:30 p.m. – Canary Room 3-4
Registration will be at 7:00 p.m.
Dinner provided at 7:30 p.m.
Presenters: Naoky Tsai, MD, clinical professor of medicine, John A. Burns School of Medicine, University of Hawaii, Manoa, Honolulu; Ashwani K. Singal MD, MS, associate professor of medicine and director of UAB Porphyria Center, division of gastroenterology and hepatology, University of Alabama at Birmingham.
Overview: This educational update will highlight the most clinically relevant advances in the management of patients with cirrhosis and hepatic encephalopathy (HE). The symposium will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients with cirrhosis and HE.
Target audience: This activity has been designed to meet the educational needs of physicians, advanced practice providers, and allied health professionals who provide care for hospitalized patients with liver disease.
Learning objectives:
- Understand the complications and the consequences of chronic liver disease.
- Describe the economic, patient, and caregiver burdens associated with cirrhosis and HE.
- Demonstrate the ability to properly treat HE patients and prevent recurrence of disease.
Accredited by: Rehoboth McKindley Christian Health Care Services
Provided by: Chronic Liver Disease Foundation (CLDF)
Register: http://www.chronicliverdisease.org/
Supported by an educational grant from Salix Pharmaceuticals.
Valuable Strategies to Reduce the Risk for and Clinical Impact of Hyperkalemia
7:30 – 9:30 p.m. – Canary Room 1-2
Dinner provided at 7:30 p.m.
Presenters: Biff F. Palmer, MD, professor of internal medicine, University of Texas Southwestern Medical Center, Dallas; Robert Toto, MD, associate dean, clinical and translational research, director, Center for Translational Medicine, UT Southwestern Medical Center, Dallas.
Overview: The goal of the case-based symposium is to highlight patients at increased risk of recurrent or sustained hyperkalemia and how these patients may be managed with evidence-based treatment so that they are able to continue renin-angiotensin-aldosterone system inhibitor therapy, if appropriate. The presenters will share their experiences in managing these patients, including suggestions for the hospitalist’s role in continued care.
Accreditation: This activity has been approved for AMA PRA Category 1 Credit(s)™. See final CE activity announcement for specific details.
This activity is supported by an educational grant from Relypsa Inc.
Hepatology News Tonight: Managing Complication of Cirrhosis
7:30 – 9:30 p.m. – Canary Room 3-4
Registration will be at 7:00 p.m.
Dinner provided at 7:30 p.m.
Presenters: Naoky Tsai, MD, clinical professor of medicine, John A. Burns School of Medicine, University of Hawaii, Manoa, Honolulu; Ashwani K. Singal MD, MS, associate professor of medicine and director of UAB Porphyria Center, division of gastroenterology and hepatology, University of Alabama at Birmingham.
Overview: This educational update will highlight the most clinically relevant advances in the management of patients with cirrhosis and hepatic encephalopathy (HE). The symposium will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients with cirrhosis and HE.
Target audience: This activity has been designed to meet the educational needs of physicians, advanced practice providers, and allied health professionals who provide care for hospitalized patients with liver disease.
Learning objectives:
- Understand the complications and the consequences of chronic liver disease.
- Describe the economic, patient, and caregiver burdens associated with cirrhosis and HE.
- Demonstrate the ability to properly treat HE patients and prevent recurrence of disease.
Accredited by: Rehoboth McKindley Christian Health Care Services
Provided by: Chronic Liver Disease Foundation (CLDF)
Register: http://www.chronicliverdisease.org/
Supported by an educational grant from Salix Pharmaceuticals.
Valuable Strategies to Reduce the Risk for and Clinical Impact of Hyperkalemia
7:30 – 9:30 p.m. – Canary Room 1-2
Dinner provided at 7:30 p.m.
Presenters: Biff F. Palmer, MD, professor of internal medicine, University of Texas Southwestern Medical Center, Dallas; Robert Toto, MD, associate dean, clinical and translational research, director, Center for Translational Medicine, UT Southwestern Medical Center, Dallas.
Overview: The goal of the case-based symposium is to highlight patients at increased risk of recurrent or sustained hyperkalemia and how these patients may be managed with evidence-based treatment so that they are able to continue renin-angiotensin-aldosterone system inhibitor therapy, if appropriate. The presenters will share their experiences in managing these patients, including suggestions for the hospitalist’s role in continued care.
Accreditation: This activity has been approved for AMA PRA Category 1 Credit(s)™. See final CE activity announcement for specific details.
This activity is supported by an educational grant from Relypsa Inc.
Hepatology News Tonight: Managing Complication of Cirrhosis
7:30 – 9:30 p.m. – Canary Room 3-4
Registration will be at 7:00 p.m.
Dinner provided at 7:30 p.m.
Presenters: Naoky Tsai, MD, clinical professor of medicine, John A. Burns School of Medicine, University of Hawaii, Manoa, Honolulu; Ashwani K. Singal MD, MS, associate professor of medicine and director of UAB Porphyria Center, division of gastroenterology and hepatology, University of Alabama at Birmingham.
Overview: This educational update will highlight the most clinically relevant advances in the management of patients with cirrhosis and hepatic encephalopathy (HE). The symposium will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients with cirrhosis and HE.
Target audience: This activity has been designed to meet the educational needs of physicians, advanced practice providers, and allied health professionals who provide care for hospitalized patients with liver disease.
Learning objectives:
- Understand the complications and the consequences of chronic liver disease.
- Describe the economic, patient, and caregiver burdens associated with cirrhosis and HE.
- Demonstrate the ability to properly treat HE patients and prevent recurrence of disease.
Accredited by: Rehoboth McKindley Christian Health Care Services
Provided by: Chronic Liver Disease Foundation (CLDF)
Register: http://www.chronicliverdisease.org/
Supported by an educational grant from Salix Pharmaceuticals.